locus that is necessary for incorporation of viral RNA into virions. Although we have found a similar locus within the 5' portion of the gag gene of RSV (unpublished data), we describe here a second cis-acting locus that is needed for proper incorporation of RSV RNA into virus particles. This locus is found within the 115-nucleotide element near the 3' end of the genome. An RSV viral RNA genome must contain both the 5' portion of gag and at least a portion of a single 115-nucleotide element to be packaged properly.
The genome of Rous sarcoma virus (RSV) contains two 115-nucleotide sequences that have approximately 80% nucleotide homology (1, 17, 22) . These sequences are in the same genomic orientation, forming a direct repeat that flanks the transforming gene, v-src, in the 3' end of the genome. Many transformation-defective variants of RSV have lost the complete v-src sequence and retain a single hybrid copy of the 115-nucleotide sequence (15, 25) . Moreover, the 3' ends of the Rous-associated virus-O (5), Y73 virus (7), and Fujinami virus (19) genomes contain a sequence that is highly homologous to the 115-nucleotide sequence of RSV. Because no Rous sarcoma-avian leukosis virus genome has yet been identified that lacks both copies of the 115-nucleotide sequence, the possibility that this sequence performs a necessary function was investigated.
The RNA sequences involved in the recognition of viral RNA by viral proteins during virion assembly have not been defined for RSV. A naturally occurring mutant of RSV, SE21Q1b, does not export its own RNA, nor is its RNA exported by a superinfecting helper virus (10) . Although the 5' end of the SE21Q1b genome bears a 150-nucleotide deletion (18) , the relationship between the deletion and the phenotype has not been fully characterized. The regions upstream from the gag gene of spleen necrosis virus (23) and Moloney murine leukemia virus (12) have been shown to contain a cis-acting t Paper BCR3040 of the Research Institute of Scripps Clinic. locus that is necessary for incorporation of viral RNA into virions. Although we have found a similar locus within the 5' portion of the gag gene of RSV (unpublished data), we describe here a second cis-acting locus that is needed for proper incorporation of RSV RNA into virus particles. This locus is found within the 115-nucleotide element near the 3' end of the genome. An RSV viral RNA genome must contain both the 5' portion of gag and at least a portion of a single 115-nucleotide element to be packaged properly.
MATERIALS AND METHODS Chemicals and enzymes. DNA polymerase and restriction enzymes were purchased from New England Biolabs; T4 polynucleotide kinase was purchased from P-L Biochemicals, Inc.; agarose and S1 nuclease were purchased from Sigma Chemical Co.
Preparation of cloned retrovirus DNA. The large circular form of the DNA of Schmidt-Ruppin strain A of RSV, cloned as a permuted linear molecule into XgtWES, was a gift from W. DeLorbe (2) . Viral DNA was digested with restriction enzymes PvuII and Sacl, and the long terminal repeat (LTR)-containing fragment (from the PvuII site near the 3' end of v-src to the Sacl site 150 nucleotides downstream from U5) was subcloned into a pBR322 derivative containing single PvuII and Sacl sites. The plasmid was digested with PvuII (the site is shown in Fig. 1 ) and then with exonuclease Bal31 (12) . The 4, 350) . In summary, the manipulations described above created a plasmid that contained a single RSV LTR with minimal viral flanking sequences.
The wild-type RSV genome shown in Fig. 2 was constructed by inserting the remainder of the RSV genome into a unique EcoRI site within the LTR region of the LTR-containing plasmid. This was performed by coligating several purified subgenomic fragments with the LTR plasmid which had been cut with EcoRI and treated with alkaline phosphatase (12) . The v-src gene was then deleted from the provirus-containing plasmid from the AccI site at position 882 (Fig. 1A) to the PvuII site at position 2,673 (Fig. 1A) Fig. 7 ) was constructed by digesting pr779/-273 DNA to completion with restriction enzymes ClaI and PvuII (the PvuII site was within the gag gene near its 5' end), modifying the DNA with the large fragment of E. coli DNA polymerase, and ligating the DNA to ClaI linkers. We chose a recombinant that had incorporated a ClaI linker in the gap that was left by deletion of env, pol, and most of gag. Proviruses pr779/-29/E#7 and pr779/-29/E#11 (see Fig. 7 ) were constructed by digesting pr779/-29 with ClaI and ligating the DNA to the StuI-to-NdeI fragment (Fig. 1A) , which had been modified with terminal ClaI linkers. The pr779/-29/E#11 recombinant contained the 115-nucleotide element in the same transcriptional orientation as in the wild type; the pr779/-29/E#7 recombinant contained the element in the backward orientation.
All of the plasmids were amplified with chloramphenicol and purified by two cesium chloride bandings after Triton X-100 lysis (12 (14) . The procedures used for RNA isolation and S1 nuclease analysis have been described previously (21) . The 814-nucleotide AvaIl fragment (Fig. 1A ) was 3'-endlabeled and used to detect deletions of the RSV RNA genome upstream from v-src. The 3,100-nucleotide EcoRI fragment (Fig. 1A) was 5'-end-labeled and used to detect deletions downstream from v-src. To determine the amount of splicing that occurred at the gag 5' splice site, the Hinfl-to-BamHI fragment (see Fig. 5 ) was subcloned into a nonviral plasmid containing other Hinfl sites. All Hinfl sites were 3'-end-labeled, and the gag-containing fragment was purified by preparative electrophoresis and used as a probe for S1 nuclease analysis.
Labeling of viral proteins. Infected fibroblasts in 60-mm plates were placed in methionine-free medium for 10 min at 42 h after DNA transfection. The medium was changed to 0.5 ml of methionine-free medium supplemented with 300 ,Ci of [35S]methionine (>800 Cilmmol). The cells were incubated at 37°C for 1 h, and then 4 ml of methionine-rich medium was added. The preparations were incubated at 37°C for another 4 h. The medium was then centrifuged at 4500 rpm for 15 min, and the supematant was layered over 5 either 28 h, 48 h, or 7 days posttransfection. Figure 3 , lane A, shows the S1 nuclease digestion products after hybridization of a 3'-endlabeled 814-nucleotide Avall restriction fragment (Fig. 1A) to the total RNA from cells that had been cotransfected 28 h earlier with equal amounts of plasmids pr882/-29 and pr779/-29. As shown in Fig. 1 (Fig. 3, lane B) .
A 5'-end-labeled 3,100-nucleotide EcoRI restriction fragment (Fig. 1A ) was used as a probe to distinguish mutants pr779/-29 and pr779/-273 after cotransfection. As shown in Fig. 1 To assess the effect of the 115-nucleoti4e sequence on the levels of viral RNA exported within virions, both intracellular RNA and virion RNA from the same plate of cells were measured 48 h posttransfection. Figure 4 , lane A, shows the Si nuclease digestion products after hybridization of the 3'-end-labeled 814-nucleotide AvaIl fragment (Fig. 1A) Figure 4 , lane B, shows the Si nuclease digestion products after hybridization of the same probe to virion RNA harvested 48 h posttransfection from the culture medium of the same plate of cells used in the analysis shown in Fig.  4 , lane A. The ratio of pr779/-29 RNA to pr882/-29 RNA within the virions was markedly less than the ratio within the cells. To rule out the possibility that intracellular viral RNA levels must reach a certain threshold before being packaged, pr779/-29 and pr882/-29 DNAs were co-transfected in a 15:1 ratio; the respective RNAs were present intracellularly in a ratio of 2:1, but again only pr882/-29 RNA could be detected within the virions (data not shown). The level of RNA within the virions produced by mutant pr779/-273, measured by the same technique, was equivalent to the level in pr882/-29 (data not shown). Since mutant pr779/-273 contained the downstream 115-nucleotide sequence and mutant pr882/-29 contained the upstream 115-nucleotide sequence, we concluded that the information necessary for this effect on virion RNA levels was encoded within each 115-nucleotide sequence.
We tested the effect of deleting a portion of the polypurine region (a cis-lethal mutation [20] ) on the intracellular and virion RNA levels posttransfection. Figure 4 , lane C, shows the S1 nuclease digestion products after hybridization of the 3,100-nucleotide 5'-end-labeled EcoRI fragment (Fig. 1A) to the total intracellular RNA from cells cotransfected 48 h earlier with equal amounts of pr882/-29 and pr882/-8 DNAs. Figure  4 , lane D, shows the S1 nuclease digestion products after hybridization of the same probe to virion RNA harvested 48 h posttransfection from the culture medium of the same plate of cells used in the analysis shown in Fig. 4 , lane C.
These data show that deletion of a necessary portion of the polypurine region did not affect the levels of intracellular or virion RNA 48 h posttransfection. They also demonstrate that reinfection was not necessary to produce detectable levels of RNA within virions since pr882/-8 was incapable of reinfection. Figure 4 , lanes C and D, also show that cellular and virion RNA levels were not affected by deletion of the 21 most-downstream nucleotides in the 115-nucleotide direct repeat, thus separating the polypurine locus from the locus responsible for the effect shown in Fig. 4, lanes A and B. The studies described above demonstrated that the viral RNA genomes lacking both 115-nucleotide elements were blocked somewhere along the normal pathway from cell nucleus to virus particle. In an effort to determine better at which step in this pathway the block occurred, the following experiments were done. The cytoplasmic RNA from cells transfected with a mutant or wild-type genome was fractionated by using oligodeoxythymidylic acid-cellulose. Polyadenylic acid-containing RNA was then analyzed by S1 nuclease mapping (Fig. 5) . The DNA probe for the S1 nuclease analysis was obtained by subcloning the Hinfl-to-BamHI fragment (Fig. 5 ) into a nonviral plasmid and then 3'-end-labeling the DNA after Hinfl digestion. When this probe was hybridized to viral RNA and the hybrids were digested with S1 nuclease, a 332-nucleotide fragment was created if the probe had hybridized to viral RNA that had been spliced in the 5' end of gag (4) . A 470-nucleotide fragment was created if the probe had hybridized to viral RNA that had not been spliced at the gag splice site. Figure 5 shows that the polyadenylic acid-containing cytoplasmic viral RNAs that were produced by cells transfected with either pr779/-29 or wild-type DNA were spliced in roughly equal proportions. Thus, nuclear processing of mutant viral RNA and export into the cytoplasm appeared to be occurring normally.
Cells transfected with mutant viral DNA were then tested for the synthesis and export of viral proteins. Cells were pulse-labeled for 1 . Thus, the mutant RNA lacking both 115-hucleotide sequences was translated, and the gag polypeptide was processed and exported. However, the levels of p27 and p15 in the culture medium were consistently lower after transfection of pr779/-29 DNA than after transfection of any of the other mutant DNAs. To determine whether this was due to a fourfoldlower level of pr779/-29 RNA (Fig. 3) or due to some block at the level of virion export, the following experiment was done. A DNA mutant, pr779/-273/P#3, was constructed, in which all of the env and pol coding regions and most of the gag coding region were deleted (Fig. 7) , but the mutant retained the downstream 115-nucleotide sequence, both LTRs, the 5' leader region, and 470 nucleotides of the 5' portion of the gag coding region. When pr779/-273/P#3 DNA was transfected into cells, wild-type levels of viral RNA were produced transiently; and when pr779/-273/P#3 DNA was cotransfected with wild-type DNA, both RNA species were packaged into virions and exported normally (data not shown). Thus, pr779/-273/P#3 RNA contained all of the cis-acting sequences needed for normal RNA packa&ing into virions. -29/E#1 show that the StuI-to-NdeI fragment (Fig. 1A) was inserted into the ClaI site of pr779/-29 in either orientation. bp, Base Pair.
did not markedly influence the relative amounts of p27 and p15 found in the virions. Moreover, the intensities of the p27 and p15 bands, compared with the 21,000-dalton band, roughly paralleled the ratio of pr779/-29 RNA to pr779/-273/P#3 RNA found intracellularly (data not shown). Thus, it appeared that the lower levels of pr779/-29 translation products found in virions simply reflected the lower levels of this RNA intracellularly posttransfection and were not due to a lack of a packagable viral RNA within the cells.
To guarantee that the phenotype observed in mutant pr779/-29 was actually due to the lack of a 115-nucleotide element and not due to an unanticipated mutation in some other region of the genome accidentally introduced during cloning in E. coli, a single copy of the upstream 115-nucleotide element (Stul-to NdeI fragment [Fig. 1] ) was introduced in either orientation into the ClaI site of plasmid pr779/-29 (Fig. 7) . When the element was inserted in the normal orientation, the DNA was infectious upon transfection (high levels of reverse transcriptase after 2 weeks). However, when the element was inserted backwards, the DNA was not infectious, and the RNA carried a cis-acting defect. Thus, proper insertion of the 115-nucleotide element back into pr779/-29 repaired the defect, discounting any possibility of a relevant defect in another region of the pr779/-29 genome.
DISCUSSION
The measurement of reverse transcriptase levels 2 weeks after transfection demonstrated that at least one copy of the 115-nucleotide direct repeat of RSV was necessary for normal viral growth after transfection of viral DNA (Fig. 2) . In an attempt to determine the function(s) of the 115-nucleotide sequence, viral RNA transcripts were analyzed soon after transfection. Figure 3 shows that inclusion of either copy of the 115-nucleotide sequence within the viral genome increased the intracellular viral RNA level (measured 28 h posttransfection) approximately fourfold. The 115-nucleotide sequence clearly acted in cis to elevate the viral RNA levels. The fourfold difference in RNA levels was not due to reinfection by the infectious virus since the cislethal mutant pr882/-8 (20) was able to produce wild-type levels of RNA 28 h posttransfection (Fig. 4) . Figure 4 shows that transfection of viral DNA lacking both copies of the 115-nucleotide element led to the production of viral RNA intracellularly, but that the viral RNA was not detectable within virions. The experiment shown in Fig. 5 was done to rule out the possibility of a gross defect in RNA processing or export from the nucleus. The experiment shown in Fig. 6 demonstrated that mutant viral transcripts were translated normally and that the gag translation product appeared to be exported and cleaved normally (although at lower levels due to lower levels of mutant viral mRNA).
There are two ways to explain the observation that pr779/-29 intracellular RNA is present at lower levels than the intracellular RNA produced by a genome containing a 115-nucleotide element (Fig. 3) . The 115-nucleotide element influences either the amount of transcription or the stability of the RNA (or both). The observation that insertion of one copy of the 115-nucleotide element back into mutant pr779/-29 repaired the defect when it was placed in the normal orientation but not when it was placed in the backward orientation diminishes the possibility that this repeated element functioned solely as a viral enhancer element (enhancer elements are known to increase transcription during transient expression experiments when they are linked in either orientation to genes in cis [6] ). However, it has been reported recently that approximately 40 nucleotides adjacent to the polypurine tract of the downstream 115-nucleotide element are part of an enhancing element which extends downstream about 90 nucleotides into U3 (11) . Deletion of the region within the 115-nucleotide element decreases the frequency of stable biochemical transformation (another test for enhancing elements [6] ) sevenfold (11) . Our transient expression data (Fig. 3 and 4) are consistent with the hypothesis that the 115-nucleotide element contains a portion of an overlapping enhancer locus. However, a decreased transcription rate alone cannot account for the differential distribution of mutant RNA between virions and cytoplasm. Some other cisacting mechanism must be involved.
Since the 115-nucleotide element lies within the viral RNA transcript, differential RNA stability must be considered. If the 115-nucleotide element did affect stability, it would do so by interacting with or preventing the interaction with a cellular or viral molecule (since the rate of spontaneous RNA degradation at neutral pH is negligible). One possibility is that the pool of full-length viral RNA bound to viral proteins (and thus hypothetically stabilized) is large, such that the lack of this interaction (pool) would decrease the amount of total intracellular RNA.
Although this is an attractive hypothesis, one would expect the ratio of unspliced viral RNA to spliced viral mRNA to decrease markedly in a mutant RNA that was unable to bind to stabilizing viral proteins. However, Fig. 5 Figure 5 again makes this possibility seem unlikely, and Fig. 6 shows that pr779/-29 RNA is translated in direct proportion to its lower total concentration. Although it is formally possible that the 115-nucleotide element protects viral RNA from a cellular RNase, there is no a priori reason to suspect it. Although we retain RNase sensitivity as a formal possibility and realize that this type of RNA instability could be invoked as a mechanism to explain the lowered levels of virion RNA, we do not favor this explanation since one would expect to see a gradually decreasing concentration of genomic RNA en route to the periphery of the cell and thus a lowered ratio of full-length viral RNA to spliced viral RNA in pr779/-29-transfected cells.
Therefore, we favor the hypothesis that pr779/-29 RNA is present in lower levels because it is synthesized in lower amounts (presumably due to deletion of a portion of the overlapping enhancer element) and that pr779/-29 RNA is as stable as wild-type RNA. Thus, the decreased ratio of pr779/-29 RNA to pr882/-29 RNA in virions must be explained by the ability of some mechanism in the periphery of the cell to distinguish pr882/-29 RNA from pr779/-29 RNA. The most likely mechanism is the mechanism which is involved in the packaging of viral RNA into virions.
The murine retroviruses have very few nucleotides separating the 3' end of the envelope gene from the polypurine tract, and it has been shown that deleted spleen necrosis virus genomes are packaged normally even when they retain only 40 nucleotides upstream from U3 (in addition to U5 and the upstream packaging locus [23] ). Therefore, neither of these viral genomes appears to have an equivalent cis-acting locus upstream from the polypurine tract. However, it is known that the enhancer elements of murine retroviruses are contained entirely within U3 120 to 200 nucleotides downstream from the polypurine-U3 junction. This downstream skewing of the enhancer element (relative to RSV) leads us to suspect that a locus equivalent to the one contained within the 115-nucleotide element of RSV may be present in the U3 region of murine retroviruses and, perhaps, spleen necrosis virus. Although it has been shown that Harvey sarcoma virus genomes lacking U3 can be packaged, the event occurs at such a low frequency that it does not disprove the possibility of a packaging locus in U3 (3) . An alternative argument is that RSV is unique in its arrangement of cis-acting packaging loci and that no equivalent to the 115-nucleotide element exists in other viruses.
Although the genomes shown in Fig. 7B and C establish without a doubt that the 115-nucleotide element is required for proper viral replication, it is not obvious why the virus evolved in this way. If the exclusion of subgenomic mRNAs from virions is controlled by a packaging locus within the normal viral intron, why should the genome contain a similar locus in its exonic sequences? One possibility is that the locus lies within the intron of an alternative spliced RNA species. Another possibility is that two packaging loci must interact to fold the RNA into a conformation that is suitable for packaging.
